DHODH Antibody (Rabbit mAb) [N8E14]

Application: Reactivity: Mouse, Rat, Human

Usage Information

Dilution
WB1:1000

Application
WB

Reactivity
Mouse, Rat, Human

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW Observed MW
43 kDa 43 kDa
^*Why do the predicted and actual molecular weights differ? The following reasons may explain differences between the predicted and actual protein molecular weight. Post-translational modifications(e.g., phosphorylation, glycosylation); Splice variants and isoforms; Relative charge; Multimerization.

Datasheet & SDS

Biological Description

Specificity
DHODH Antibody (Rabbit mAb) [N8E14] detects endogenous levels of total DHODH protein.

Clone
N8E14

Synonym(s)
DHOdehase, Dihydroorotate oxidase, DHODH

Background
Dihydroorotate dehydrogenase, DHODH, is a flavin mononucleotide-dependent flavoprotein anchored to the outer surface of the inner mitochondrial membrane, where an N-terminal bipartite sequence combining a mitochondrial targeting signal and a membrane stop-transfer sequence governs its import and anchoring, while the catalytic core forms an alpha/beta-barrel domain housing the FMN cofactor and dihydroorotate binding site. DHODH catalyzes the fourth and rate-limiting step of de novo pyrimidine biosynthesis, oxidizing dihydroorotate to orotate while reducing its bound FMN to FMNH2, and this reduced flavin is then reoxidized by transferring electrons directly to ubiquinone within the inner mitochondrial membrane, physically coupling pyrimidine synthesis to the mitochondrial electron transport chain rather than operating as an isolated cytosolic reaction; the resulting electrons feed forward through ubiquinol-cytochrome c oxidoreductase and cytochrome c oxidase, contributing to the mitochondrial electrochemical gradient. Because ubiquinone serves as its direct electron acceptor, DHODH activity depends on a functional respiratory chain, and this same ubiquinone-coupling reaction positions DHODH as a source of regenerated reduced coenzyme Q10, a lipophilic antioxidant that scavenges lipid peroxyl radicals and suppresses mitochondrial lipid peroxidation, placing DHODH alongside GPX4 and FSP1 as a parallel, mitochondria-specific defense system against ferroptotic cell death; impairing DHODH activity removes this antioxidant regeneration function and sensitizes mitochondria to lipid peroxidation-driven death. In actively proliferating T and B lymphocytes, DHODH-dependent pyrimidine synthesis is essential to sustain nucleotide demand, and pharmacological inhibition of DHODH by teriflunomide interferes with oxidative phosphorylation and aerobic glycolysis in activated T cells specifically through functional inhibition of respiratory chain complex III, with this metabolic disruption preferentially suppressing proliferation of high-affinity T cell clones and altering T cell receptor repertoire diversity in patients with relapsing-remitting multiple sclerosis. DHODH contains a hydrophobic tunnel lined with residues including Gln47, His56, and Arg136, which allows ubiquinone to access the FMN cofactor, and this same tunnel is competitively occupied by teriflunomide, which inhibits DHODH with nanomolar potency by directly competing with ubiquinone.

Background

Dihydroorotate dehydrogenase, DHODH, is a flavin mononucleotide-dependent flavoprotein anchored to the outer surface of the inner mitochondrial membrane, where an N-terminal bipartite sequence combining a mitochondrial targeting signal and a membrane stop-transfer sequence governs its import and anchoring, while the catalytic core forms an alpha/beta-barrel domain housing the FMN cofactor and dihydroorotate binding site. DHODH catalyzes the fourth and rate-limiting step of de novo pyrimidine biosynthesis, oxidizing dihydroorotate to orotate while reducing its bound FMN to FMNH2, and this reduced flavin is then reoxidized by transferring electrons directly to ubiquinone within the inner mitochondrial membrane, physically coupling pyrimidine synthesis to the mitochondrial electron transport chain rather than operating as an isolated cytosolic reaction; the resulting electrons feed forward through ubiquinol-cytochrome c oxidoreductase and cytochrome c oxidase, contributing to the mitochondrial electrochemical gradient. Because ubiquinone serves as its direct electron acceptor, DHODH activity depends on a functional respiratory chain, and this same ubiquinone-coupling reaction positions DHODH as a source of regenerated reduced coenzyme Q10, a lipophilic antioxidant that scavenges lipid peroxyl radicals and suppresses mitochondrial lipid peroxidation, placing DHODH alongside GPX4 and FSP1 as a parallel, mitochondria-specific defense system against ferroptotic cell death; impairing DHODH activity removes this antioxidant regeneration function and sensitizes mitochondria to lipid peroxidation-driven death. In actively proliferating T and B lymphocytes, DHODH-dependent pyrimidine synthesis is essential to sustain nucleotide demand, and pharmacological inhibition of DHODH by teriflunomide interferes with oxidative phosphorylation and aerobic glycolysis in activated T cells specifically through functional inhibition of respiratory chain complex III, with this metabolic disruption preferentially suppressing proliferation of high-affinity T cell clones and altering T cell receptor repertoire diversity in patients with relapsing-remitting multiple sclerosis. DHODH contains a hydrophobic tunnel lined with residues including Gln47, His56, and Arg136, which allows ubiquinone to access the FMN cofactor, and this same tunnel is competitively occupied by teriflunomide, which inhibits DHODH with nanomolar potency by directly competing with ubiquinone.

References
https://pubmed.ncbi.nlm.nih.gov/31043571/ https://pubmed.ncbi.nlm.nih.gov/41369379/

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%